Vilya Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.

Repeat Founder
Top 100 in Health Diagnostics
Top 100 in Life Science
Top 100 in Health Diagnostics in United States
Top 100 in Medical in United States
Top 100 in Biotechnology in United States
Top 100 in Life Science in United States
Company Highlights
Year Founded

2022

icon-altEmployees

47

Location (HQ)

USA

Since Last Funding

6 months

Monthly Website Visitors

1.2K

icon-altTotal Investment Amt

$71M

icon-altMoM Headcount Growth

4.43%

icon-altYoY Headcount Growth

61.86%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Biotechnology Research

Medical

Life Science

Health Diagnostics